Published in J Altern Complement Med on February 20, 2007
Description of clinical risk factor changes during naturopathic care for type 2 diabetes. J Altern Complement Med (2009) 1.08
Whole blood viscosity determination in diabetes management: perspective in practice. N Am J Med Sci (2009) 1.07
Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med (2011) 0.88
Adjunctive naturopathic care for type 2 diabetes: patient-reported and clinical outcomes after one year. BMC Complement Altern Med (2012) 0.84
Laboratory evaluations to optimize outcomes of antioxidant nutrition therapy in diabetes management. N Am J Med Sci (2009) 0.77
Wellness can be achieved through understanding and addressing the elements of metabolic syndrome. J Altern Complement Med (2007) 0.76
Effects of CoQ10 Supplementation on Lipid Profiles and Glycemic Control in Patients with Type 2 Diabetes: a randomized, double blind, placebo-controlled trial. J Diabetes Metab Disord (2014) 0.75
Disease Prevention and Health Promotion: How Integrative Medicine Fits. Am J Prev Med (2015) 0.75
Rosmarinic acid ameliorates hyperglycemia and insulin sensitivity in diabetic rats, potentially by modulating the expression of PEPCK and GLUT4. Drug Des Devel Ther (2016) 0.75
Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA (2003) 2.69
Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J Am Diet Assoc (2003) 2.11
A pilot whole systems clinical trial of traditional Chinese medicine and naturopathic medicine for the treatment of temporomandibular disorders. J Altern Complement Med (2008) 2.10
Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med (2002) 1.85
The intersecting paradigms of naturopathic medicine and public health: opportunities for naturopathic medicine. J Altern Complement Med (2011) 1.55
Echinacea purpurea for prevention of upper respiratory tract infections in children. J Altern Complement Med (2005) 1.40
Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells. Clin Cancer Res (2010) 1.20
The use of complementary and alternative medical providers by insured cancer patients in Washington State. Cancer (2004) 1.14
Quality of life at the end of life. Health Qual Life Outcomes (2007) 1.14
High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum (2007) 1.12
Sex differences in motives for use of complementary and alternative medicine among cancer patients. Altern Ther Health Med (2004) 1.09
Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer. ISRN Oncol (2012) 1.08
Description of clinical risk factor changes during naturopathic care for type 2 diabetes. J Altern Complement Med (2009) 1.08
Naturopathic medicine and type 2 diabetes: a retrospective analysis from an academic clinic. Altern Med Rev (2006) 1.07
Attachment and quality of life in patients with inflammatory bowel disease. Int J Colorectal Dis (2014) 1.04
Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR spectroscopy and chemometric analyses. J Proteome Res (2009) 1.01
TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy. Clin Cancer Res (2011) 1.00
Ascorbic acid and rates of cognitive decline in Alzheimer's disease. J Alzheimers Dis (2009) 0.98
Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol (2006) 0.98
Observed Changes in Risk during Naturopathic Treatment of Hypertension. Evid Based Complement Alternat Med (2011) 0.97
Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer. J Altern Complement Med (2013) 0.96
Use of complementary and alternative medicine (CAM) by Washington State hospices. Am J Hosp Palliat Care (2008) 0.96
Might massage or guided meditation provide "means to a better end"? Primary outcomes from an efficacy trial with patients at the end of life. J Palliat Care (2009) 0.95
Burden of illness in Italian patients with gastro-oesophageal reflux disease. Curr Med Res Opin (2005) 0.93
Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C. J Clin Gastroenterol (2008) 0.92
Evaluating CAM treatment at the end of life: a review of clinical trials for massage and meditation. Complement Ther Med (2006) 0.92
Survival in HIV-1-positve adults practicing psychological or spiritual activities for one year. Altern Ther Health Med (2007) 0.91
Patient-reported experiences with first-time naturopathic care for type 2 diabetes. PLoS One (2012) 0.91
Urease-positive bacteria other than Helicobacter pylori in human gastric juice and mucosa. Am J Gastroenterol (2006) 0.89
Complementary and alternative medicine in multiple sclerosis: survey of licensed naturopaths. J Altern Complement Med (2004) 0.87
The naturopathic medical research agenda: the future and foundation of naturopathic medical science. J Altern Complement Med (2006) 0.86
Psychometric validation of the italian translation of the gastrointestinal symptom-rating scale and quality of life in reflux and dyspepsia questionnaire in patients with gastro-oesophageal reflux disease. Clin Drug Investig (2004) 0.86
MRI evaluation of metal acupuncture needles. Acupunct Med (2013) 0.86
Binaural beat technology in humans: a pilot study to assess neuropsychologic, physiologic, and electroencephalographic effects. J Altern Complement Med (2007) 0.85
Evidence for correlations between distant intentionality and brain function in recipients: a functional magnetic resonance imaging analysis. J Altern Complement Med (2005) 0.84
Adjunctive naturopathic care for type 2 diabetes: patient-reported and clinical outcomes after one year. BMC Complement Altern Med (2012) 0.84
Replicable functional magnetic resonance imaging evidence of correlated brain signals between physically and sensory isolated subjects. J Altern Complement Med (2005) 0.84
Binaural beat technology in humans: a pilot study to assess psychologic and physiologic effects. J Altern Complement Med (2007) 0.83
Involvement in decision-making about treatment and ovarian cancer survivor quality of life. Gynecol Oncol (2011) 0.81
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls. J Behav Med (2012) 0.81
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing. Inflamm Bowel Dis (2010) 0.81
Extramedullary myeloid tumour of the stomach and duodenum presenting without acute myeloblastic leukemia: a diagnostic and therapeutic challenge. Leuk Lymphoma (2008) 0.81
Applying principles from complex systems to studying the efficacy of CAM therapies. J Altern Complement Med (2010) 0.81
HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report. Dig Dis Sci (2005) 0.81
Identification of mobile lipids in human cancer tissues by ex vivo diffusion edited HR-MAS MRS. Oncol Rep (2009) 0.80
Mucosal healing in pediatric Crohn's disease after anti-TNF therapy: a long-term experience at a single center. Eur J Gastroenterol Hepatol (2014) 0.78
Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry. J Chromatogr A (2009) 0.78
Role of conventional therapies in the era of biological treatment in Crohn's disease. World J Gastroenterol (2011) 0.78
The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis. Expert Rev Gastroenterol Hepatol (2015) 0.78
Survey of CAM interest, self-care, and satisfaction with health care for type 2 diabetes at group health cooperative. BMC Complement Altern Med (2011) 0.77
A randomized pilot study of naturopathic medicine in multiple sclerosis. J Altern Complement Med (2008) 0.77
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? Int J Colorectal Dis (2013) 0.77
The role of Budesonide-MMX in active ulcerative colitis. Expert Rev Gastroenterol Hepatol (2014) 0.76
Low Doses of Traditional Nanophytomedicines for Clinical Treatment: Manufacturing Processes and Nonlinear Response Patterns. J Nanosci Nanotechnol (2015) 0.76
Risk of duodenal adenomas in familial adenomatous polyposis to progress toward advanced neoplastic disease. J Clin Oncol (2004) 0.75
Adverse events associated with complementary and alternative medicine use in ovarian cancer patients. Integr Cancer Ther (2013) 0.75
Three lessons from a randomized trial of massage and meditation at end of life: patient benefit, outcome measure selection, and design of trials with terminally ill patients. Am J Hosp Palliat Care (2009) 0.75
No matter how well done, [corrected] HIV/AIDS CAM utilization papers in 2006 make us sad. J Altern Complement Med (2006) 0.75
Rescue therapy: ciclosporin or infliximab? Expert Rev Clin Immunol (2013) 0.75
Are Additional Lipid Measures Useful? Integr Med (Encinitas) (2008) 0.75
Omeprazole and ultrastructural modifications occurring in reflux esophagitis. Gastroenterology (2002) 0.75
Methodological considerations for future controlled influenza treatment trials in complementary and alternative medicine. J Altern Complement Med (2010) 0.75
A framework for credentialing naturopathic physicians in academic health centers: Oregon Health and Science University. J Altern Complement Med (2013) 0.75
A survey of complementary and alternative medicine (CAM) awareness among neurosurgeons in Washington State. J Altern Complement Med (2009) 0.75